A variety of assay technologies continue to be developed for high-thro
ughput screening. These include cell-based assays, surrogate systems u
sing microbial cells such as yeast and bacterial two-hybrid and three-
hybrid systems, and systems to measure nucleic acid-protein and recept
or-ligand interactions. Modifications have been developed for cell-fre
e, homogeneous assay systems, such as time-resolved fluorescence, fluo
rescence polarization and the scintillation proximity assay. Innovatio
ns in engineering and chemistry have led to delivery systems for nanol
iter volumes and sensitive biosensors for ultrahigh-throughout screeni
ng conducted in nanoliter and picoliter volumes. Spectroscopic methods
have been extended to read single molecule fluorescence. Technologies
are being developed to identify new targets from genomic information
in order to design the next generation of screens.